Yes I also am wondering why there is a public consultation on this. Surely usually decisions around treatment options for complex medical issues are made by groups of experts in the field, guided by the clinical evidence base. I mean, they are in every other medical field aren't they? Treatments are developed, closely trialled in clinical trials, efficacy and side effect profile determined, cost-benefit analysis applied and then either recommended for use clinically, or not.
I imagine patient groups/focus groups might be used in the guideline development process, but I'd still think it far more important that the robust clinical evidence is what's guiding the decision. And if there isn't enough robust clinical evidence to support the treatment or its effectiveness or safety, then it shouldn't be offered.
We don't see public consultations about whether patients with a specific gene mutation cancer should be offered particular new chemotherapy drugs, for example. That decision is delegated to experts who can interpret the very complex research.
Why should children suffering gender related distress deserve any less rigorous a process than any other medical or mental health condition?